Ligand profile
ZINC3881960
Virtual-screening candidate from ZINC.
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3881960- UniProt (similar protein)
P0AEK4- Tanimoto
- 1.000
- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 139.8
- −1 ≤ LogP ≤ 5 0.45
- MW ≤ 500 Da 390.4
- LogP ≤ 5 0.45
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 139.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
OC[C@@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@H](O)[C@@H]1OOC[C@@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@H](O)[C@@H]1O
InChI=1S/C20H22O8/c21-10-16-17(24)18(25)19(26)20(28-16)27-15-8-12(7-14(23)9-15)2-1-11-3-5-13(22)6-4-11/h1-9,16-26H,10H2/b2-1+/t16-,17+,18+,19+,20+/m0/s1InChI=1S/C20H22O8/c21-10-16-17(24)18(25)19(26)20(28-16)27-15-8-12(7-14(23)9-15)2-1-11-3-5-13(22)6-4-11/h1-9,16-26H,10H2/b2-1+/t16-,17+,18+,19+,20+/m0/s1
HSTZMXCBWJGKHG-ZMSCKBSRSA-NHSTZMXCBWJGKHG-ZMSCKBSRSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL142652
- Homolog
- P0AEK4
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3881960 →
- ZINC ZINC20 ZINC3881960 →
- UniProt UniProt P0AEK4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3881960”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 60
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).